Inspire Investing, LLC Nektar Therapeutics Transaction History

Inspire Investing, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$0.53 - $1.03 $83,637 - $162,541	157,807 Added 40.08%	551,556 $319,000
Q1 2023 Apr 24, 2023	BUY	$0.64 - $3.15 $184,480 - $907,987	288,250 Added 273.23%	393,749 $275,000
Q4 2022 Jan 26, 2023	BUY	$2.03 - $4.28 $82,677 - $174,315	40,728 Added 62.88%	105,499 $0
Q3 2022 Nov 07, 2022	BUY	$3.04 - $5.14 $26,995 - $45,643	8,880 Added 15.89%	64,771 $207,000
Q2 2022 Aug 10, 2022	BUY	$3.17 - $6.17 $37,910 - $73,787	11,959 Added 27.22%	55,891 $212,000
Q1 2022 Apr 21, 2022	BUY	$4.16 - $13.72 $108,022 - $356,267	25,967 Added 144.54%	43,932 $237,000
Q4 2021 Feb 14, 2022	BUY	$10.83 - $18.41 $194,560 - $330,735	17,965 New	17,965 $243,000
Q4 2021 Feb 03, 2022	SELL	$10.83 - $18.41 $137,270 - $233,346	-12,675 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$13.07 - $18.84 $165,662 - $238,797	12,675 New	12,675 $228,000
Q2 2020 Aug 12, 2020	SELL	$16.86 - $23.44 $320 - $445	-19 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$14.47 - $27.96 $274 - $531	19 New	19 $0
Q1 2018 Apr 13, 2018	SELL	$57.4 - $108.44 $169,904 - $320,982	-2,960 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$23.02 - $60.5 $68,139 - $179,080	2,960	2,960 $177,000

152

131M

92.7K

4.9K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.